« Kansas Prescription Monitoring Program: What do Wholesalers Have to do With It? | Main | Goodbye DDMAC, Hello OPDP »

08/30/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a013480eeb51f970c014e8b19c331970d

Listed below are links to weblogs that reference The OIG’s Interesting Reversal in the Solomon Case:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Chrsitopher Cavallaro

You mean the OIG finally did something right next it might be Congress doing something right even though I seriously doubt it.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Enter your email address:

Pharmaspective

CONTRIBUTORS

Learn more About Us
Related Posts Plugin for WordPress, Blogger...